|
Real-time Estimate
Cboe BZX
15:59:56 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 2.615 USD | +0.97% |
|
0.00% | +45.00% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.97% | 0.00% | +12.50% | +33.16% | +45.00% | +63.12% | +37.37% | +62.11% | -57.90% | 209M | |
| +0.07% | -1.33% | +3.49% | +7.58% | +7.99% | +57.29% | +107.90% | +347.15% | +1,378.16% | 1,034B | |
| +1.30% | +4.76% | +9.44% | +24.72% | +34.54% | +56.42% | +73.28% | +59.06% | +132.51% | 663B | |
| -0.63% | +1.02% | +6.40% | +20.11% | +14.14% | +23.10% | +78.50% | +133.64% | +303.64% | 462B | |
| +2.09% | -3.20% | +0.82% | +15.11% | +8.62% | +36.07% | +37.41% | -2.46% | +46.77% | 344B | |
| 0.00% | +3.26% | +3.73% | +16.21% | +19.82% | +29.76% | +46.97% | +55.50% | +68.79% | 307B | |
| +1.42% | +0.26% | +5.62% | -8.05% | -11.92% | -0.52% | +13.62% | +42.74% | +147.73% | 251B | |
| +0.29% | +1.62% | +17.21% | +31.29% | +35.67% | +56.44% | +74.82% | +96.17% | +159.93% | 239B | |
| -0.03% | -1.11% | -1.62% | +8.61% | -7.29% | -15.87% | -53.65% | -5.01% | +97.87% | 207B | |
| -0.21% | +1.52% | +15.23% | +17.16% | +23.13% | +33.76% | +101.08% | +110.02% | +94.05% | 186B | |
| -0.79% | +2.76% | +15.04% | +13.63% | +15.64% | +16.15% | -18.61% | -38.53% | -17.19% | 165B | |
| +0.26% | +1.84% | +18.46% | +30.18% | +22.99% | +40.59% | +60.11% | +181.55% | +482.18% | 141B | |
| +0.62% | +1.49% | +3.78% | +24.17% | +25.96% | +43.04% | +12.05% | +3.56% | +19.29% | 138B | |
| -1.15% | -2.58% | +2.42% | +3.88% | -7.80% | -9.75% | -22.65% | -13.53% | +8.57% | 107B | |
| +0.27% | +0.78% | -2.25% | +0.81% | +2.30% | +27.19% | +35.88% | +0.97% | -9.20% | 101B | |
| +0.67% | -2.45% | -0.78% | -9.71% | -16.56% | +5.69% | +55.79% | +59.21% | +507.78% | 70.85B | |
| +1.44% | +0.82% | +7.16% | +21.81% | +22.19% | +30.85% | +31.00% | +60.15% | +25.44% | 58.62B | |
| +0.33% | +0.47% | +2.68% | +44.69% | +33.32% | +79.84% | -3.01% | +3.46% | -48.02% | 56.01B | |
| -1.43% | -2.50% | -15.74% | -5.85% | -23.50% | -33.83% | +9.73% | -0.63% | +175.93% | 44.63B | |
| -2.30% | -3.22% | -1.30% | +11.33% | -4.59% | -3.53% | +13.27% | - | - | 43.54B | |
| Average | +0.25% | -0.61% | +5.12% | +15.04% | +11.98% | +26.79% | +34.54% | +60.80% | +185.07% | 230.99B | |
| Weighted average by Cap. | +0.47% | -0.76% | +5.99% | +14.68% | +14.00% | +36.00% | +57.93% | +121.40% | +418.27% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
